The recently published EORTC 62092 trial (STRASS) examines abdominal recurrence in patients after surgical resection of retroperitoneal sarcomas.  This randomized study compared these recurrences in patients receiving neoadjuvant radiation versus those undergoing surgery alone.  Rebecca Gladdy MD, PhD and Ashleigh Guadagnolo, MD join moderator and SSO Sarcoma Disease Site Work Group Chair, Aimee Crago, MD, PhD, to provide insight and analysis from both surgical and radiation oncology perspectives, discussing how this practice-changing trial is altering the approach to patients with these diseases.